Home Page
News Lines
Classifieds
Real Estate
Arcade Games
Events
Business Directory
Used Cars
Towns
Long Island New York
Loading
 
 

BIOTECHNOLOGY NEWS LINES

Advertisement



Swiss billionaires buy Merck Serono HQ for biotech campus

The new logo of bio pharmaceutical company Merck Serono SA is pictured outside the new headquarters in GenevaBy Caroline Copley ZURICH (Reuters) - Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish a biotech research campus. After selling the family business to German drugmaker Merck KGaA for $13.3 billion in 2006, the Harvard Business School graduate went on to win the Ameri......




UK tries out new model for gene testing in cancer patients

A tray containing cancer cells sits on an optical microscope in the Nanomedicine Lab at UCL's School of Pharmacy in LondonBy Kate Kelland LONDON (Reuters) - Britain launched a research program on Monday that should eventually allow all cancer patients to have access to the kind of genetic analysis that led Hollywood star Angelina Jolie to decide to undergo a double mastectomy. The project, involving the Institute of Cancer Research (ICR) in London, the U.S. gene seque......




Affymetrix CFO Barabe to retire in June Affymetrix Chief Financial Officer Tim Barabe is planning to retire from his post next month. The genetic testing instrument business said Monday that it is promoting Gavin Wood to the position. Barabe's ...


Stem cells recovered from cloned human embryos

This undated image made available by the Oregon Health & Science University in May 2013 shows developing cloned human embryos. Scientists have finally recovered stem cells from cloned human embryos, a longstanding goal that could lead to new treatments for such illnesses as Parkinson's disease and diabetes. In the Wednesday, May 15, 2013 edition of the journal Cell, scientists at the Oregon Health & Science University report harvesting stem cells from six embryos. Shoukhrat Mitalipov, who led the research, said the success came not from a single technical innovation, but from revising a series of steps in the process. (AP Photo/Oregon Health & Science University)NEW YORK (AP) ? Scientists have finally recovered stem cells from cloned human embryos, a longstanding goal that could lead to new treatments for such illnesses as Parkinson's disease and diabetes.





Scientists Report First Success in Cloning Human Stem Cells It?s been 17 years since Dolly the sheep was cloned from a mammary cell. And now scientists applied the same technique to make the first embryonic-stem-cell lines from human skin cells.


Idaho spud giant bets on biotech potatoes

This Friday, May 10, 2013 photo shows a genetically engineered potato poking through the soil of a planting pot inside J.R. Simplot's lab in southwestern Idaho. Simplot is seeking U.S. regulatory approval to market the potatoes _ which resist browning and are designed to produce lower levels of potentially cancer-causing acrylamide when fried _ to growers and, eventually, consumers. (AP Photo/John Miller)BOISE, Idaho (AP) ? A dozen years after a customer revolt forced Monsanto to ditch its genetically engineered potato, an Idaho company aims to resurrect high-tech spuds.





Scientists create human stem cells through cloning

Handout photo showing the extraction of the nucleus from an egg cellBy Sharon Begley NEW YORK (Reuters) - After more than 15 years of failures by scientists around the world and one outright fraud, biologists have finally created human stem cells by the same technique that produced Dolly the cloned sheep in 1996: They transplanted genetic material from an adult cell into an egg whose own DNA had been removed. The r......




FDA approves genetic test for lung cancer drug The Food and Drug Administration on Tuesday approved a genetic test from Roche to help doctors identify patients who can benefit from a lung cancer drug made by the company's Genentech unit. The diagnostic ...


FDA approves Roche diagnostic for gene mutation in lung cancer

Logo of Swiss pharmaceutical company Roche is pictured in Rotkreuz(Reuters) - U.S. health regulators on Tuesday approved a test developed by Roche for a specific gene mutation present in about 10 percent of non-small cell lung cancers, and said the company's drug Tarceva could be used as an initial treatment in patients with the mutation whose cancer has spread beyond the lungs. This marks the first companio......




Gene test may help guide prostate cancer treatment

Prostate cancer patient Dean Smith, left, a retired marketing executive, meets with Dr. Peter Carroll, right, at the UCSF Medical Center in San Francisco on Thursday, May 2, 2013. Carroll, chairman of urology at the University of California, San Francisco says a study he led on a new prostate cancer test - the Oncotype DX Genomic Prostate Score - suggested it could triple the number of men known to be at such low risk for aggressive disease that monitoring is a clearly safe option. Conversely, the test also suggested that some tumors were more aggressive than doctors had believed. (AP Photo/Eric Risberg)A new genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it.





You can save this news page by submitting it to your favorite sites: Social Bookmark News

All News Lines - Local and World Wide, Updated Hourly


Long Island News Press Releases


RSS news lines are HTML instructions and not actual copy. They are displayed here through the doctrine of fair use in the U.S. Copyright Act which allows us to show snippets and links to news and other materials. The fair use doctrine protects limited uses of content, such as indexing to make it easier to find. This allows us to send visitors to breaking news web sites. If your news appears here against your wishes please contact us for removal, disable your RSS feeds or implement simple technical standards such as robots.txt or metatags to prevent search engines (Yahoo and MSN) from feeding us your snippets and links.

 

 
   By using this site you agree to our Terms of Service and Privacy Policy. If you do not agree, please exit the service.
   Copyright © 2002 - 2013 Long Island Exchange ® Inc. All rights reserved. Internet Marketing by Searchen Networks ® Inc.